Datar, Cancer

Datar Cancer Genetics Introduces Revolutionary Tumor-Agnostic + Informed Blood Test for Residual Disease Monitoring

Published on 08/07/2025 at 18:03 | prnewswire.co.uk

Datar Cancer Genetics Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom United States of America England India

en | boerse | 67994378 |